Browse: Departments Dates Agencies
SUBJECT CATEGORY: National Cancer Institute; Notice of Closed Meetings
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
[[Page 69212]]
as amended. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel; Development and Discovery.
Date: February 79, 2007.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Peter J. Wirth, PhD, Scientific Review
Administrator, Research Programs Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8131, Bethesda, MD 208928328. 3014967565.
pw2q@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SPORE II.
Date: February 1315, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Caron Lyman, Scientific Review Administrator,
Division of Extramural Activities, National Cancer Institute,
National Institutes of Health, 6116 Executive Blvd, Room 8119,
Bethesda, MD 208928328. 3014514761. lymanc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.93.392, Cancer
Construction;93.393, Cancer Cause and Prevention Research;93.394,
Cancer Detection and Diagnosis Research;93.395, Cancer Treatment
Research;93.396, Cancer Biology Research;93.397, Cancer Centers
Support;93.398, Cancer Research Manpower;93.399, Cancer Control, National Institutes of Health, HHS)
Dated: November 20, 2006.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 069469 Filed 112906; 8:45 am]
BILLING CODE 414001M
SUMMARY: National Cancer Institute,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
[[Page 69212]]
as amended. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel; Development and Discovery.
Date: February 79, 2007.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Peter J. Wirth, PhD, Scientific Review
Administrator, Research Programs Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8131, Bethesda, MD 208928328. 3014967565.
pw2q@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SPORE II.
Date: February 1315, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Caron Lyman, Scientific Review Administrator,
Division of Extramural Activities, National Cancer Institute,
National Institutes of Health, 6116 Executive Blvd, Room 8119,
Bethesda, MD 208928328. 3014514761. lymanc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.93.392, Cancer
Construction;93.393, Cancer Cause and Prevention Research;93.394,
Cancer Detection and Diagnosis Research;93.395, Cancer Treatment
Research;93.396, Cancer Biology Research;93.397, Cancer Centers
Support;93.398, Cancer Research Manpower;93.399, Cancer Control, National Institutes of Health, HHS)
Dated: November 20, 2006.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 069469 Filed 112906; 8:45 am]
BILLING CODE 414001M
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 47 CFR Part 73 26 CFR Part 1 40 CFR Part 180 33 CFR Part 117 50 CFR Part 17 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 40 CFR Part 63 33 CFR Part 100 50 CFR Part 622 50 CFR Part 660 44 CFR Part 65 26 CFR Part 301 39 CFR Part 111 40 CFR Part 300 6 CFR Part 5 40 CFR Part 271 47 CFR Part 64 40 CFR Parts 52 and 81 50 CFR Part 665 10 CFR Part 50 44 CFR Part 64 49 CFR Part 571 39 CFR Part 3020